BioMarin Pharmaceutical Income After Taxes 2010-2024 | BMRN
BioMarin Pharmaceutical income after taxes for the twelve months ending September 30, 2024 was $0.322B, a 119.21% increase year-over-year.
- BioMarin Pharmaceutical annual income after taxes for 2023 was $0.168B, a 18.43% increase from 2022.
- BioMarin Pharmaceutical annual income after taxes for 2022 was $0.142B, a 320.91% decline from 2021.
- BioMarin Pharmaceutical annual income after taxes for 2021 was $-0.064B, a 107.5% decline from 2020.